DRUG

sotagliflozin

2 hypotheses across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for sotagliflozin

Pancreatic cancer 2

Mediator Outcome Score Tier Lit. status Trial
SGLT2 pancreatic adenocarcinoma 0.208 Mid novel signal none
SGLT2 prostate adenocarcinoma 0.208 Mid novel signal none

Clinical trials

54 registered trials for sotagliflozin

Source: ClinicalTrials.gov

← All drugs